南新制药(688189)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688189 南新制药

交易中 05-16 14:27:46

{"stockData":{"symbol":"688189","market":"SH","secType":"STK","nameCN":"南新制药","latestPrice":6.56,"timestamp":1747376866000,"preClose":6.48,"halted":0,"volume":3269787,"delay":0,"changeRate":0.0123,"floatShares":274000000,"shares":274000000,"eps":-1.397,"marketStatus":"交易中","change":0.08,"latestTime":"05-16 14:27:46","open":6.46,"high":6.59,"low":6.43,"amount":21366200,"amplitude":0.0247,"askPrice":6.57,"askSize":416,"bidPrice":6.56,"bidSize":176,"shortable":0,"etf":0,"ttmEps":-1.397,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1747378800000},"marketStatusCode":2,"adr":0,"adjPreClose":6.48,"symbolType":"stock_kcb","openAndCloseTimeList":[[1747359000000,1747366200000],[1747371600000,1747378800000]],"highLimit":7.13,"lowLimit":5.83,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":274400000,"isCdr":false,"pbRate":1.91,"roa":"--","roe":"--","epsLYR":-1.3007,"committee":-0.250469,"marketValue":1800000000,"turnoverRate":0.0119,"status":0,"floatMarketCap":1800000000},"requestUrl":"/m/hq/s/688189","defaultTab":"news","newsList":[{"id":"2532900200","title":"南新制药（688189）2025年一季报简析：净利润减143.66%，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2532900200","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532900200?lang=zh_cn&edition=full","pubTime":"2025-05-01 06:38","pubTimestamp":1746052723,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期南新制药发布2025年一季报。截至本报告期末，公司营业总收入4062.48万元，同比下降70.21%，归母净利润-802.83万元，同比下降143.66%。本报告期南新制药三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达36.59%。财报体检工具显示：建议关注公司现金流状况持有南新制药最多的基金为大成景恒混合A，目前规模为3.17亿元，最新净值2.6977，较上一交易日上涨1.05%，近一年上涨34.19%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050100004749.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688189"],"gpt_icon":0},{"id":"2531881680","title":"南新制药截止03月31日股东人数8843.00户，人均持股3.10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2531881680","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531881680?lang=zh_cn&edition=full","pubTime":"2025-04-30 15:44","pubTimestamp":1745999086,"startTime":"0","endTime":"0","summary":"南新制药披露公司股东人数最新情况，截止2025年03月31日，公司股东人数为8843.00户，较上期减少226户，环比减少0.47%。在化学制药行业个股中，南新制药股东户数少于行业平均水平，截至2025年03月31日，化学制药行业平均股东户数为3.45万户，户均持股市值方面，化学制药行业A股上市公司户均持股市值为76.47万元，南新制药少于行业平均水平。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430165825a6ce960f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430165825a6ce960f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688189"],"gpt_icon":0},{"id":"2531703757","title":"南新制药：对公司未来发展的信心和对公司价值的认可","url":"https://stock-news.laohu8.com/highlight/detail?id=2531703757","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531703757?lang=zh_cn&edition=full","pubTime":"2025-04-30 15:33","pubTimestamp":1745998401,"startTime":"0","endTime":"0","summary":"南新制药回复：您好，感谢您对公司的关注，公司本次推出回购股份计划，主要基于对公司未来发展的信心和对公司价值的认可，回购的股份将全部用于股权激励或员工持股计划，有利于提升团队凝聚力、研发能力和公司核心竞争力，有效地将股东利益、公司利益和员工个人利益紧密结合在一起，通过激励核心经营管理团队和骨干员工，促进员工、公司及股东三方成为更紧密绑定的利益共同体。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025043000026746.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688189"],"gpt_icon":0},{"id":"2531703777","title":"南新制药：公司高度认可创新研发对企业发展的重要意义","url":"https://stock-news.laohu8.com/highlight/detail?id=2531703777","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531703777?lang=zh_cn&edition=full","pubTime":"2025-04-30 15:33","pubTimestamp":1745998388,"startTime":"0","endTime":"0","summary":"证券之星消息，南新制药04月30日在投资者关系平台上答复投资者关心的问题。其他研发工作也正有序推进。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025043000026721.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688189","BK0239"],"gpt_icon":0},{"id":"2531280796","title":"图解南新制药一季报：第一季度单季净利润同比减313.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531280796","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531280796?lang=zh_cn&edition=full","pubTime":"2025-04-30 03:50","pubTimestamp":1745956213,"startTime":"0","endTime":"0","summary":"证券之星消息，南新制药2025年一季报显示，公司主营收入4062.48万元，同比下降70.21%；归母净利润-802.83万元，同比下降143.66%；扣非净利润-828.84万元，同比下降146.27%；负债率28.21%，财务费用50.02万元，毛利率52.0%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025043000002124.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688189"],"gpt_icon":0},{"id":"2531624397","title":"图解南新制药年报：第四季度单季净利润同比减9292.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531624397","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531624397?lang=zh_cn&edition=full","pubTime":"2025-04-30 01:50","pubTimestamp":1745949008,"startTime":"0","endTime":"0","summary":"证券之星消息，南新制药2024年年报显示，公司主营收入2.63亿元，同比下降63.44%；归母净利润-3.57亿元，同比下降3183.79%；扣非净利润-3.59亿元，同比下降10020.21%；其中2024年第四季度，公司单季度主营收入3671.39万元，同比下降79.89%；单季度归母净利润-2.85亿元，同比下降9292.85%；单季度扣非净利润-2.86亿元，同比下降5588.91%；负债率28.15%，财务费用-145.87万元，毛利率54.59%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025043000001169.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688189"],"gpt_icon":0},{"id":"2531764705","title":"南新制药：2025年第一季度净利润约-803万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531764705","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531764705?lang=zh_cn&edition=full","pubTime":"2025-04-30 01:04","pubTimestamp":1745946295,"startTime":"0","endTime":"0","summary":"每经AI快讯，南新制药（SH 688189，收盘价：6.07元）4月30日发布一季度业绩公告称，2025年第一季度营收约4062万元，同比减少70.21%；归属于上市公司股东的净利润亏损约803万元。每经头条（nbdtoutiao）——航班停飞、列车瘫在轨道上、ATM机关闭……欧洲史上最大规模停电，超5000万人受影响！网络攻击？罕见大气现象？还没找到原因(记者 王可然)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043001052094e7d584&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043001052094e7d584&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688189"],"gpt_icon":0},{"id":"2531036757","title":"南新制药：一季度净亏损802.83万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531036757","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531036757?lang=zh_cn&edition=full","pubTime":"2025-04-29 23:25","pubTimestamp":1745940328,"startTime":"0","endTime":"0","summary":"格隆汇4月29日丨南新制药(688189.SH)公布2025年第一季度报告，公司实现营业收入4062.48万元，同比下降70.21%；归属于上市公司股东的净利润-802.83万元；归属于上市公司股东的扣除非经常性损益的净利润-828.84万元；基本每股收益-0.0293元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429232528974a5be4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429232528974a5be4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688189"],"gpt_icon":0},{"id":"2529522422","title":"南新制药04月23日主力净流出31万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2529522422","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529522422?lang=zh_cn&edition=full","pubTime":"2025-04-23 15:21","pubTimestamp":1745392900,"startTime":"0","endTime":"0","summary":"04月23日, 南新制药股价跌0.32%，报收6.16元，成交金额2120万元，换手率1.25%，振幅1.94%，量比0.96。南新制药今日主力资金净流出31万元，上一交易日主力净流入204万元。|04月23日主力加仓幅度排名||#|股票简称|主力净额占比|#|健尔康|8.43%|#|新天地|7.95%|#|利安科技|7.56%|#|...|...|#2753|南新制药|-0.02%|南新制药所在的化学制药行业，今日主力净流出1.78亿元，行业排名28/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423163030a4639f71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423163030a4639f71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688189","BK0239"],"gpt_icon":0},{"id":"2529700349","title":"南新制药04月22日主力净流入204万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2529700349","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529700349?lang=zh_cn&edition=full","pubTime":"2025-04-22 15:20","pubTimestamp":1745306404,"startTime":"0","endTime":"0","summary":"04月22日, 南新制药股价涨0.82%，报收6.18元，成交金额2386万元，换手率1.42%，振幅2.12%，量比1.13。南新制药今日主力资金净流入204万元，上一交易日主力净流出12万元。该股近5个交易日下跌0.48%，主力资金累计净流入248万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出1253万元，其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422160145a6c3738d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422160145a6c3738d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688189","BK0239"],"gpt_icon":0},{"id":"2529588153","title":"化学制药行业盘中拉升，威尔药业涨9.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529588153","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529588153?lang=zh_cn&edition=full","pubTime":"2025-04-22 09:44","pubTimestamp":1745286262,"startTime":"0","endTime":"0","summary":"04月22日，化学制药行业盘中拉升，截至09点44分，化学制药行业整体指数上涨1.01%，报10985.070点。从个股上来看，该行业的成分股中，威尔药业涨9.09%，富祥药业、东诚药业等4只股涨幅超过5%。从资金上来看，截止发稿，化学制药行业主力净流入为-1.59亿，其中东诚药业受到资金热捧，主力净流入2513.18万；拉长时间线来看，该板块近20日主力资金净流入-68.34亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422094422a6c316d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422094422a6c316d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603538","600267","600488","688356","600513","688166","688578","BK0275","688076","605177","BK0188","688247","600380","603676","603707","688117","600420","603229","688091","603811","BK0239","688513","605507","BK0028","688690","688799","688505","688189","600521","600789","688566","600216","603351","600276","688506","BK0060","600624","600613","600812","605116","600196"],"gpt_icon":0},{"id":"2516147680","title":"核心产品降价、股价早已破发 南新制药再度陷入亏损泥潭","url":"https://stock-news.laohu8.com/highlight/detail?id=2516147680","media":"北京商报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516147680?lang=zh_cn&edition=full","pubTime":"2025-03-03 20:08","pubTimestamp":1741003685,"startTime":"0","endTime":"0","summary":"随着抗流感病毒药物市场竞争愈发激烈，主要依靠核心产品帕拉米韦氯化钠注射液的南新制药业绩将再度陷入亏损。核心产品被迫降价南新制药提到，核心产品销售价格进行下调，导致公司报告期内营业收入和毛利率下降。在二级市场上，南新制药股价整体走下坡路，目前已出现破发。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303201947a25d1aca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303201947a25d1aca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688189"],"gpt_icon":0},{"id":"2514877117","title":"南新制药：2024年净亏损3.54亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514877117","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514877117?lang=zh_cn&edition=full","pubTime":"2025-02-27 18:59","pubTimestamp":1740653954,"startTime":"0","endTime":"0","summary":"格隆汇2月27日丨南新制药公布2024年度业绩快报，报告期内，公司生产经营活动正常。截至2024年12月31日，公司总资产123,373.35万元，比上年同期减少29.00%；归属于母公司的所有者权益95,387.82万元，比上年同期减少27.63%；归属于母公司所有者的每股净资产3.4762元，比上年同期减少27.63%。报告期内，公司实现营业收入27,398.33万元，比上年同期减少63.20%；实现营业利润-39,189.22万元，实现利润总额-39,246.55万元，实现归属于母公司所有者的净利润-35,423.77万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227185914abdf304f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227185914abdf304f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688189"],"gpt_icon":0},{"id":"2514874815","title":"南新制药：公司正在加快推进帕拉米韦吸入溶液三期临床试验工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2514874815","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514874815?lang=zh_cn&edition=full","pubTime":"2025-02-27 17:54","pubTimestamp":1740650041,"startTime":"0","endTime":"0","summary":"有投资者向南新制药提问， 请问帕拉米韦吸入溶液三期临床，此次流感季完成全部人员入组了么？公司回答表示，尊敬的投资者： 您好！公司正在加快推进帕拉米韦吸入溶液三期临床试验工作，目前进展顺利，相关事项具体情况公司将及时履行信息披露义务，感谢您的关注和支持！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227180559abdf1fea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227180559abdf1fea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688189","BK0239"],"gpt_icon":0},{"id":"2514287553","title":"南新制药2024年业绩快报：归母净利润亏损3.54亿元，同比降9542.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514287553","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514287553?lang=zh_cn&edition=full","pubTime":"2025-02-27 17:22","pubTimestamp":1740648147,"startTime":"0","endTime":"0","summary":"2月27日，南新制药发布公告，2024年度业绩快报显示，公司营业总收入为2.74亿元，同比下降63.2%；营业利润为-3.92亿元，利润总额为-3.92亿元，归母净利润约亏损3.54亿元。报告期内，公司归母净利润同比下降幅度达到9542.56%。此外，公司在报告期内继续对各类资产计提资产减值损失及信用减值损失，进一步加剧了亏损情况。总资产和归母权益分别较上年同期减少29%和27.63%。2024年前三季度，南新制药实现收入2.27亿元，归母净利润-7184万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502271723119894b817&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502271723119894b817&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688189"],"gpt_icon":0},{"id":"2513440137","title":"南新制药02月24日获主力加仓264万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513440137","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513440137?lang=zh_cn&edition=full","pubTime":"2025-02-24 18:54","pubTimestamp":1740394461,"startTime":"0","endTime":"0","summary":"02月24日, 南新制药股价涨0.29%，报收6.86元，成交金额3207万元，换手率1.70%，振幅3.65%，量比1.14。南新制药今日主力资金净流入264万元，连续4日净流入，上一交易日主力净流入21万元。|02月24日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|天舟文化|7.59%|#|元道通信|4.90%|#|新研股份|4.74%|#|中设股份|4.53%|#|众辰科技|4.42%|#|福日电子|4.05%|#|南兴股份|3.97%|#|华平股份|3.70%|#|粤宏远Ａ|3.53%|#|瑞贝卡|3.43%|南新制药所在的化学制药行业，今日主力净流出5.09亿元，行业排名32/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224191022abdad040&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224191022abdad040&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688189","BK0239"],"gpt_icon":0},{"id":"2512492047","title":"南新制药02月20日获主力加仓12万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512492047","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512492047?lang=zh_cn&edition=full","pubTime":"2025-02-20 15:20","pubTimestamp":1740036046,"startTime":"0","endTime":"0","summary":"02月20日, 南新制药股价涨0.60%，报收6.72元，成交金额2035万元，换手率1.10%，振幅2.69%，量比0.82。南新制药今日主力资金净流入12万元，上一交易日主力净流入3万元。该股近5个交易日上涨2.75%，主力资金累计净流入276万元；近20日主力资金累计净流出487万元，其中净流出天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220153957abd5d34d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220153957abd5d34d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688189","BK0239"],"gpt_icon":0},{"id":"2512212496","title":"AI+医疗行业深度：AI+医药：势不可挡，未来已至","url":"https://stock-news.laohu8.com/highlight/detail?id=2512212496","media":"中邮证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512212496?lang=zh_cn&edition=full","pubTime":"2025-02-19 15:04","pubTimestamp":1739948697,"startTime":"0","endTime":"0","summary":"投资要点“AI+医疗”解决方案全球市场有望突破千亿美元，有望进入到商业化加速阶段。“AI+医疗”行业人工智能解决方案的全球市场规模预计将由2022年的137亿美元增至2030年的1,553亿美元，CAGR为35.5%，行业存在爆发式增长机会。政策面上，国内宏观政策利好AI制药，医疗AI三类证审批加速。我们认为“AI+医疗”有望应用于药物研发、癌症诊断、医学影像、手术机器人等领域，行业或迎来巨变。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219150422a24b831f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219150422a24b831f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600079","600200","601089","159938","688117","603811","688192","600851","688247","603351","BK0010","603676","605116","688578","BK0239","603520","688690","688505","688266","688799","688302","BK0185","600774","600062","600789","603229","688356","688373","605177","BK0028","603367","600380","688321","688166","688602","600624","688566","688658","600216","600521","688076","688513","688235","688382","600613","603538","600196","688553","688758","603207","603669","600513","600664","688062","605507","BK0188","688197","688091","159891","600812","600276","688428","600420","600488","688176","688189","688221","603168","BK0175"],"gpt_icon":0},{"id":"2510827757","title":"医药行业：从摩根大通医疗健康大会看生物创新药管线，关注ADC、双特异性抗体、细胞与基因治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2510827757","media":"研报虎","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510827757?lang=zh_cn&edition=full","pubTime":"2025-02-11 13:59","pubTimestamp":1739253565,"startTime":"0","endTime":"0","summary":"2025年第四十三届摩根大通医疗健康年会盛大召开。我们从本次会议的热点一窥行业创新升级的重点方向，关注抗体偶联药物、双特异性抗体、细胞与基因治疗等生物创新药领域的最新进展。2025JPM大会展示的ADC药物多达数十款，基本为第三代产品，面向肺癌、乳腺癌、肺癌等高发实体瘤，涌现出一大批创新前沿的生物技术公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211140710abca815b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211140710abca815b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0175","600200","BK0196","159760","600276","BK0188","159992","688117","688302","603367","600267","688197","603669","688658","688221","688690","BK0060","603207","688428","688513","688506","600420","BK0239","600079","601089","603229","600664","688602","BK0096","603676","600488","688266","688373","BK0187","603520","688247","BK0012","605507","600062","600380","603351","688799","BK0028","603811","600521","688321","688578","600624","603538","600613","688176","688189","603707","605116","688235","BK0183","688553","600216","600513","600774","600196","605177","688356","688505","603168","688566"],"gpt_icon":0},{"id":"2510277958","title":"医药行业周报：诺华三抗新药PIT565在华再获批临床 用于SLE","url":"https://stock-news.laohu8.com/highlight/detail?id=2510277958","media":"太平洋证券股份...","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510277958?lang=zh_cn&edition=full","pubTime":"2025-02-11 00:00","pubTimestamp":1739203200,"startTime":"0","endTime":"0","summary":"行业要闻：近日，中国国家药监局药品审评中心官网公示，诺华申报的1 类新药PIT565 获得一项新的临床试验默示许可，拟开发治疗系统性红斑狼疮。PIT565 是一款抗CD3/CD19/CD2 的三特异性抗体，可以靶向恶性B 细胞上的CD19，同时可与T 细胞上的CD3和CD2结合。与CD3 双特异性相比，通过PIT565共刺激CD2 可能会克服T 细胞衰竭，增加患者反应的深度和持续时间，该药此前在华获批针对B 细胞恶性肿瘤的IND。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211120756961eb981&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211120756961eb981&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603707","603987","688578","600216","688193","688076","688085","BK0239","688513","600613","688029","688091","600055","BK0028","600789","605369","688062","688617","688212","603976","688626","603229","688575","688606","603538","688161","603309","688117","603676","688273","600079","600200","688189","603222","600267","601089","600513","600488","688236","600812","688266","688580","688013","688677","688198","600645","600774","603520","BK0188","603387","688607","688468","688505","688576","600380","688382","603880","605507","603367","600529","688075","603207","688758","688139","603301","600521","688271","688658","603658","603205","688026","688302","600276","688358","688317","603351","688197","600851","600624","603669","688166","688192","688298","688613","600062","688602","688506","605177","600420","600664","688553","688067","688799","688373","688767","688108","688221","688581","688690","688247","603168","688235","BK0060","600196","688176","688399","688050","688428","688016","688321","600807","600587","688217","688338","603811","688389","688426","688356","605116","688151","688566"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1747376884360,"stockEarnings":[{"period":"1week","weight":0.0031},{"period":"1month","weight":0.0435},{"period":"3month","weight":-0.0241},{"period":"6month","weight":-0.1348},{"period":"1year","weight":-0.054},{"period":"ytd","weight":-0.0092}],"compareEarnings":[{"period":"1week","weight":0.0086},{"period":"1month","weight":0.0346},{"period":"3month","weight":0.0102},{"period":"6month","weight":0.015},{"period":"1year","weight":0.0836},{"period":"ytd","weight":0.0087}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"湖南南新制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"8843人(较上一季度减少0.47%)","perCapita":"31030股","listingDate":"2020-03-26","address":"湖南省长沙市浏阳市经济技术开发区康里路1号","registeredCapital":"27440万元","survey":"　　湖南南新制药股份有限公司专注于流行性感冒等抗病毒、传染病防治药品，以及恶性肿瘤、糖尿病等其他重大疾病治疗药品研发、生产与销售。主要产品是辛伐他汀分散片、帕拉米韦氯化钠注射液、乳酸环丙沙星氯化钠注射液、双赛普利、协诺信、保施泰等。公司创新药帕拉米韦氯化钠注射液开发项目获得国家“重大新药创制”科技专项支持,并成功入选国家“十二五”科技创新成就展,该产品已成为国家卫计委《流行性感冒诊疗方案(2018版)》的主要推荐药物之一,并列入国家应急产品目录。","listedPrice":34.94},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"南新制药(688189)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供南新制药(688189)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"南新制药,688189,南新制药股票,南新制药股票老虎,南新制药股票老虎国际,南新制药行情,南新制药股票行情,南新制药股价,南新制药股市,南新制药股票价格,南新制药股票交易,南新制药股票购买,南新制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"南新制药(688189)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供南新制药(688189)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}